Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Seagen Inc.
RECORDATI GROUP
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
Pfizer
Exelixis
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Stanford University
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
INSYS Therapeutics Inc